Search Page

1

Cite

Share

Aspergillus fumigatus morphology and dynamic host interactions.

van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latgé JP. van de Veerdonk FL, et al. Nat Rev Microbiol. 2017 Nov;15(11):661-674. doi: 10.1038/nrmicro.2017.90. Epub 2017 Sep 18. Nat Rev Microbiol. 2017. PMID: 28919635 Review.

Cite

Share

2

Cite

Share

Host-microbe interactions: innate pattern recognition of fungal pathogens.

van de Veerdonk FL, Kullberg BJ, van der Meer JW, Gow NA, Netea MG. van de Veerdonk FL, et al. Among authors: van der meer jw. Curr Opin Microbiol. 2008 Aug;11(4):305-12. doi: 10.1016/j.mib.2008.06.002. Epub 2008 Jul 17. Curr Opin Microbiol. 2008. PMID: 18602019 Review.

Cite

Share

3

Cite

Share

The macrophage mannose receptor induces IL-17 in response to Candida albicans.

van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, Joosten I, van den Berg WB, Williams DL, van der Meer JW, Joosten LA, Netea MG. van de Veerdonk FL, et al. Among authors: van der meer jw, van den berg wb. Cell Host Microbe. 2009 Apr 23;5(4):329-40. doi: 10.1016/j.chom.2009.02.006. Cell Host Microbe. 2009. PMID: 19380112 Free article.

Cite

Share

4

Cite

Share

Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.

Chai LY, van de Veerdonk F, Marijnissen RJ, Cheng SC, Khoo AL, Hectors M, Lagrou K, Vonk AG, Maertens J, Joosten LA, Kullberg BJ, Netea MG. Chai LY, et al. Immunology. 2010 May;130(1):46-54. doi: 10.1111/j.1365-2567.2009.03211.x. Epub 2009 Dec 2. Immunology. 2010. PMID: 20002791 Free PMC article.

Cite

Share

5

Cite

Share

Th17 responses and host defense against microorganisms: an overview.

van de Veerdonk FL, Gresnigt MS, Kullberg BJ, van der Meer JW, Joosten LA, Netea MG. van de Veerdonk FL, et al. Among authors: van der meer jw. BMB Rep. 2009 Dec 31;42(12):776-87. doi: 10.5483/bmbrep.2009.42.12.776. BMB Rep. 2009. PMID: 20044948 Free article. Review.

Cite

Share

6

Cite

Share

Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure.

van de Veerdonk FL, Kullberg BJ, Verschueren IC, Hendriks T, van der Meer JW, Joosten LA, Netea MG. van de Veerdonk FL, et al. Among authors: van der meer jw. Shock. 2010 Oct;34(4):407-11. doi: 10.1097/SHK.0b013e3181d67041. Shock. 2010. PMID: 20160669

Cite

Share

7

Cite

Share

Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy.

van de Veerdonk FL, Netea MG, Joosten LA, van der Meer JW, Kullberg BJ. van de Veerdonk FL, et al. Among authors: van der meer jw. FEMS Microbiol Rev. 2010 Nov;34(6):1063-75. doi: 10.1111/j.1574-6976.2010.00232.x. FEMS Microbiol Rev. 2010. PMID: 20528948 Free article. Review.

Cite

Share

8

Cite

Share

Candida albicans dampens host defense by downregulating IL-17 production.

Cheng SC, van de Veerdonk F, Smeekens S, Joosten LA, van der Meer JW, Kullberg BJ, Netea MG. Cheng SC, et al. J Immunol. 2010 Aug 15;185(4):2450-7. doi: 10.4049/jimmunol.1000756. Epub 2010 Jul 12. J Immunol. 2010. PMID: 20624941 Free article.

Cite

Share

9

Cite

Share

Pathogenesis of invasive candidiasis.

van de Veerdonk FL, Kullberg BJ, Netea MG. van de Veerdonk FL, et al. Curr Opin Crit Care. 2010 Oct;16(5):453-9. doi: 10.1097/MCC.0b013e32833e046e. Curr Opin Crit Care. 2010. PMID: 20711079 Review.

Cite

Share

10

Cite

Share

T-cell Subsets and Antifungal Host Defenses.

van de Veerdonk FL, Netea MG. van de Veerdonk FL, et al. Curr Fungal Infect Rep. 2010 Dec;4(4):238-243. doi: 10.1007/s12281-010-0034-6. Epub 2010 Sep 30. Curr Fungal Infect Rep. 2010. PMID: 20976286 Free PMC article.

Cite

Share